Comment on: “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal”
Crossref DOI link: https://doi.org/10.1007/s40273-017-0502-8
Published Online: 2017-04-08
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reifsnider, Odette
Hall, Fiona
Sorensen, Sonja
Proskorovsky, Irina
Girod, Isabelle
Lee, Jennifer
Funding for this research was provided by:
Janssen-Cilag Ltd
Text and Data Mining valid from 2017-04-08